JP2759325B2 - 1,2-bis (dimethylaminocinnamoyloxy) propane derivative and ultraviolet absorber containing the propane derivative - Google Patents

1,2-bis (dimethylaminocinnamoyloxy) propane derivative and ultraviolet absorber containing the propane derivative

Info

Publication number
JP2759325B2
JP2759325B2 JP15047188A JP15047188A JP2759325B2 JP 2759325 B2 JP2759325 B2 JP 2759325B2 JP 15047188 A JP15047188 A JP 15047188A JP 15047188 A JP15047188 A JP 15047188A JP 2759325 B2 JP2759325 B2 JP 2759325B2
Authority
JP
Japan
Prior art keywords
compound
mixture
propane derivative
dimethylaminocinnamoyloxy
bis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP15047188A
Other languages
Japanese (ja)
Other versions
JPH023638A (en
Inventor
義侑 島居
元博 三村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PIASUARAIZU KK
Original Assignee
PIASUARAIZU KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PIASUARAIZU KK filed Critical PIASUARAIZU KK
Priority to JP15047188A priority Critical patent/JP2759325B2/en
Publication of JPH023638A publication Critical patent/JPH023638A/en
Application granted granted Critical
Publication of JP2759325B2 publication Critical patent/JP2759325B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は、新規化合物である1,2−ビス(ジメチルア
ミノシンナモイルオキシ)プロパン誘導体と、そのプロ
パン誘導体を含有した紫外線吸収剤に関する。
Description: TECHNICAL FIELD The present invention relates to a novel compound, a 1,2-bis (dimethylaminocinnamoyloxy) propane derivative, and an ultraviolet absorbent containing the propane derivative.

(従来の技術) 従来より、紫外線吸収剤は種々の技術分野に利用され
ており、たとえば化粧品の分野においても皮膚の保護を
目的として種々の紫外線吸収剤が開発されている。
(Prior Art) Conventionally, ultraviolet absorbers have been used in various technical fields. For example, in the field of cosmetics, various ultraviolet absorbers have been developed for the purpose of protecting the skin.

ところで紫外線は、その波長領域によって一般にUV−
A(320〜400nm),UV−B(280nm〜320nm),及びUV−
C(280nm以下)に分けられるが、皮膚に対する影響に
関しては、特に上記UV−Bの領域の紫外線が紅斑や水疱
を形成し、或いは皮膚癌等の皮膚障害を生じさせること
が知られている。従って、化粧品分野での従来の紫外線
吸収剤は、UV−Bの領域の紫外線を吸収するものが大半
であった。
By the way, ultraviolet rays generally have UV-
A (320-400 nm), UV-B (280-320 nm), and UV-
C (at 280 nm or less). Regarding the effect on the skin, it is known that ultraviolet rays in the above-mentioned UV-B region form erythema and blisters, or cause skin disorders such as skin cancer. Therefore, most of the conventional ultraviolet absorbers in the cosmetics field absorb ultraviolet rays in the UV-B region.

ところが、従来において皮膚に影響をほとんど与えな
いと認識されていたUV−Aの領域の紫外線についても、
その後の研究によりシミ,ソバカス等の色素沈着や上記
UV−Bの皮膚変性の増強作用を示すことが判明した。従
って、UV−Aの紫外線を吸収する紫外線吸収剤も近年に
おいて開発されており、たとえばジベンゾイルメタン誘
導体(特開昭55−66535号,特開昭62−56454号)やベン
ゾフェノン誘導体等が知られている。
However, ultraviolet rays in the UV-A region, which was conventionally recognized as having little effect on the skin,
Subsequent studies showed that pigmentation of spots, freckles, etc.
It was found that UV-B exhibited an effect of enhancing skin degeneration. Accordingly, ultraviolet absorbers for absorbing UV-A ultraviolet rays have been developed in recent years, and for example, dibenzoylmethane derivatives (JP-A-55-66535 and JP-A-62-56454) and benzophenone derivatives are known. ing.

(発明が解決しようとする課題) しかしながら、このような従来のUV−A用の紫外線吸
収剤は、安全性,相溶性,吸収効果等のすべての点につ
いて満足のいくものはなく、必ずしも実用には供し難い
ものであった。
(Problems to be Solved by the Invention) However, such conventional UV-A UV absorbers are not satisfactory in all respects such as safety, compatibility, absorption effect and the like, and are not always practical. Was difficult to serve.

本発明はこのような問題点を解決するためになされた
もので、安全性,相溶性,吸収効果等のすべての面で良
好な紫外線吸収剤を提供することを課題とする。
The present invention has been made to solve such a problem, and an object of the present invention is to provide an ultraviolet absorber excellent in all aspects such as safety, compatibility, and absorption effect.

(課題を解決するための手段) 本発明者等はこのような課題を解決するために鋭意研
究したところ、新規物質である1,2−ビス(ジメチルア
ミノシンナモイルオキシ)プロパン誘導体がUV−Aの領
域の光を有効に吸収するだけでなく、皮膚に対する毒性
及び刺激性が全くなく、又、化粧品用の各種基剤や有機
溶剤等に対して良好な相溶性を示し、化粧品用長波長紫
外線吸収剤としても極めて有用であることを見出し、本
発明を完成した。
(Means for Solving the Problems) The present inventors have conducted intensive studies in order to solve such problems, and found that a novel substance, 1,2-bis (dimethylaminocinnamoyloxy) propane derivative, is a UV-A Not only effectively absorbs the light of the area, but also has no toxicity and irritation to the skin, and shows good compatibility with various bases and organic solvents for cosmetics, and long wavelength ultraviolet rays for cosmetics. The present inventors have found that they are extremely useful as absorbents, and have completed the present invention.

すなわち、本発明は、上記課題を解決するために、新
規物質及び紫外線吸収剤としてなされたもので、新規物
質としての構成上の要旨は、 一般式 (R1は炭素数1〜18のアルキル基又は炭素数2〜18のア
シル基、R2はオルト又はパラ位のジメチルアミノ基〔−
N(CH3)2〕を示す)で示されることにある。
That is, the present invention has been made as a novel substance and an ultraviolet absorber in order to solve the above-mentioned problems. (R 1 is an alkyl group having 1 to 18 carbon atoms or an acyl group having 2 to 18 carbon atoms, and R 2 is an ortho- or para-position dimethylamino group [−
N (CH 3 ) 2 ]).

又、紫外線吸収剤としての構成上の要旨は、上記一般
式で示される1,2−ビス(ジメチルアミノシンナモイル
オキシ)プロパン誘導体を含有することにある。
The gist of the constitution as the ultraviolet absorber is that it contains a 1,2-bis (dimethylaminocinnamoyloxy) propane derivative represented by the above general formula.

尚、本発明の上記化合物は、種々の方法で製造できる
が、次にその一例につき、上記R1がアルキル基の場合と
アシル基の場合とについて分説する。
The above-mentioned compound of the present invention can be produced by various methods. Next, an example of the case where R 1 is an alkyl group and an acyl group will be described.

先ず、R1がアルキル基の場合には、グリセリンの1,2
−ハイドロキシ部位を予めアセタール等で保護した下記
化合物〔a〕を用いて常法により合成したグリセリンモ
ノエーテル〔b〕と、ジメチルアミノケイ皮酸とを、直
接無触媒で又は一般的なエステル化触媒を用いて合成す
ることができ、或いはジメチルアミノケイ皮酸の低級ア
ルコールエステル、たとえばメチルエステル,エチルエ
ステル,プロピルエステル等とのエステル交換反応によ
って合成することができる。
First, when R 1 is an alkyl group, 1,2 of glycerin
A glycerin monoether [b] synthesized by a conventional method using the following compound [a] in which a hydroxy site is protected with an acetal or the like in advance, and dimethylaminocinnamic acid directly without a catalyst or a general esterification catalyst Or by a transesterification reaction of dimethylaminocinnamic acid with a lower alcohol ester such as methyl ester, ethyl ester, propyl ester and the like.

一方、R1がアシル基の場合には、LAWRENCE C.MITCHEL
Lの方法〔J.Am.Oil.Chem.Soc.49,281(1972)〕に従
い、1,2−ジハイドロキシ−3−クロロプロパンをジメ
チルアミノケイ皮酸クロライドでエステル化した後、カ
ルボン酸ナトリウム(R−COONa)と反応させ、所望の
1,2−ビス(ジメチルアミノシンナモイルオキシ)プロ
パン誘導体を合成することができる。
On the other hand, when R 1 is an acyl group, LAWRENCE C.MITCHEL
According to the method of L [J. Am. Oil. Chem. Soc. 49,281 (1972)], 1,2-dihydroxy-3-chloropropane is esterified with dimethylaminocinnamic acid chloride, and then sodium carboxylate (R- COONa) and react with the desired
A 1,2-bis (dimethylaminocinnamoyloxy) propane derivative can be synthesized.

さらに、ジメチルアミノケイ皮酸、必要なカルボン酸
とグリセリンを直接無触媒で合成することができ、又は
ジメチルアミノケイ皮酸、必要なカルボン酸の低級アル
コールエステルとグリセリンとのエステル交換反応によ
り容易に合成することができる。ただし、この場合に
は、上記1,2−ビス(ジメチルアミノシンナモイルオキ
シ)プロパン誘導体と、下記の構造の1,3−ビス(ジメ
チルアミノシンナモイルオキシ)プロパン誘導体〔c〕
との混合物でしか得ることはできない。
Furthermore, dimethylaminocinnamic acid, the required carboxylic acid and glycerin can be directly synthesized without a catalyst, or can be easily prepared by transesterification of dimethylaminocinnamic acid, the lower alcohol ester of the required carboxylic acid with glycerin. Can be synthesized. However, in this case, the above 1,2-bis (dimethylaminocinnamoyloxy) propane derivative and the 1,3-bis (dimethylaminocinnamoyloxy) propane derivative [c] having the following structure
Can only be obtained in a mixture with

しかも、上記1,3−ビス(ジメチルアミノシンナモイ
ルオキシ)プロパン誘導体については、光安定性の面か
ら多量の使用は好ましくない。
Moreover, it is not preferable to use a large amount of the 1,3-bis (dimethylaminocinnamoyloxy) propane derivative from the viewpoint of photostability.

(実施例) 以下、本発明の実施例について説明する。(Example) Hereinafter, an example of the present invention will be described.

実施例1 本実施例は、次式〔A〕で示される化合物〔I〕につ
いての実施例である。
Example 1 This example is an example of the compound [I] represented by the following formula [A].

1,2−ジハイドロキシ−3−(2−エチルヘキシルオ
キシ)プロパン0.51g,パラジメチルアミノケイ皮酸エチ
ル1.42g,炭酸カリウム0.1gの混合物を窒素雰囲気下で16
0〜170℃に加熱し、反応により生じるエチルアルコール
を除去した。
A mixture of 0.51 g of 1,2-dihydroxy-3- (2-ethylhexyloxy) propane, 1.42 g of ethyl para-dimethylaminocinnamate and 0.1 g of potassium carbonate was added under a nitrogen atmosphere to a mixture of 16 g.
The mixture was heated to 0 to 170 ° C. to remove ethyl alcohol generated by the reaction.

2時間反応後、冷却し、クロロホルム60mlを加えた反
応液を5%水酸化カリウム水溶液、続いて水で十分に洗
浄した後、硫酸マグネシウム上で乾燥し、溶媒を除去し
た。
After reacting for 2 hours, the reaction solution was cooled, and the reaction solution to which 60 ml of chloroform was added was sufficiently washed with a 5% aqueous solution of potassium hydroxide and then with water, and then dried over magnesium sulfate to remove the solvent.

これによって得られた残査を溶出液として酢酸エチル
とジクロロメタンとの混合物(3:97)を用いたシリカゲ
ルカラムクロマトグラフィーで精製を行い、0.6gの淡黄
の粘稠な油状物質である次式〔A〕の化合物〔I〕を得
た。
The residue thus obtained was purified by silica gel column chromatography using a mixture of ethyl acetate and dichloromethane (3:97) as an eluent, and 0.6 g of a pale yellow viscous oily substance represented by the following formula: Compound [I] of [A] was obtained.

尚、上記化合物〔I〕のNMRを測定したところ、下記
のとおりであった。
The NMR of the compound [I] was measured and found to be as follows.

NMRの測定に際し、核種としては1Hを用い、又、溶媒
としてCDCl3,化学シフトδppmの算出のための標準とし
てテトラメチルシラン(TMS)を用いた。さらに、共鳴
周波数は60MHzで測定した。
In the NMR measurement, 1 H was used as a nuclide, CDCl 3 was used as a solvent, and tetramethylsilane (TMS) was used as a standard for calculating a chemical shift δ ppm. Further, the resonance frequency was measured at 60 MHz.

0.6−1.1(m,6H),1.1−1.6(m,9H),3.03(s,12H),
3.40(d,2H,J=5Hz),3.68(d,2H,J=5Hz),4.45(d,2
H,J=5Hz),5.2−5.6(1H),6.25(d,2H,J=16Hz),6.6
5(d,4H,J=9Hz),7.44(d,4H,J=9Hz),7.67(d,2H,J
=16Hz 実施例2 本実施例は、次式〔B〕で示される化合物〔II〕につ
いての実施例である。
0.6-1.1 (m, 6H), 1.1-1.6 (m, 9H), 3.03 (s, 12H),
3.40 (d, 2H, J = 5Hz), 3.68 (d, 2H, J = 5Hz), 4.45 (d, 2
H, J = 5Hz), 5.2−5.6 (1H), 6.25 (d, 2H, J = 16Hz), 6.6
5 (d, 4H, J = 9 Hz), 7.44 (d, 4H, J = 9 Hz), 7.67 (d, 2H, J
= 16 Hz Example 2 This is an example of the compound [II] represented by the following formula [B].

出発物質として上記実施例1の1,2−ジハイドロキシ
−3−(2−エチルヘキシルオキシ)プロパンに代え
て、1,2−ジハイドロキシ−3−(1,1−ジメチルエチル
オキシ)プロパン0.37gを用い、実施例1と同様の操作
によって0.5gの淡黄結晶である化合物〔II〕を得た。
尚、この化合物〔II〕の融点は、184〜188℃であった。
又、この化合物〔II〕についてNMRを測定したところ、
次のとおりであった。
As a starting material, 0.37 g of 1,2-dihydroxy-3- (1,1-dimethylethyloxy) propane was used instead of 1,2-dihydroxy-3- (2-ethylhexyloxy) propane of Example 1 above. Using the same procedure as in Example 1, 0.5 g of compound [II] as pale yellow crystals was obtained.
The melting point of this compound [II] was 184 to 188 ° C.
Also, when NMR was measured for this compound [II],
It was as follows.

尚、測定条件は上記実施例1と同様である。 The measurement conditions are the same as in Example 1 above.

1.20(s,9H),3.02(s,12H),3.62(d,2H,J=5Hz),
4.47(d,2H,J=5Hz),5.1−5.5(1H),6.25(d,2H,J=1
6Hz),6.66(d,4H,J=9Hz),7.43(d,4H,J=9Hz),7.66
(d,2H,J=16Hz) 実施例3 本実施例は、次式〔C〕の化合物と、次式〔D〕の化
合物との混合物〔III〕についての実施例である。
1.20 (s, 9H), 3.02 (s, 12H), 3.62 (d, 2H, J = 5Hz),
4.47 (d, 2H, J = 5Hz), 5.1-5.5 (1H), 6.25 (d, 2H, J = 1
6Hz), 6.66 (d, 4H, J = 9Hz), 7.43 (d, 4H, J = 9Hz), 7.66
(D, 2H, J = 16 Hz) Example 3 This example is an example of a mixture [III] of a compound of the following formula [C] and a compound of the following formula [D].

グリセリン0.56g,パラジメチルアミノケイ皮酸エチル
1.46g,2−エチルヘキサン酸エチル1.14g,炭酸カリウム
0.1gを使用し、実施例1と同様の操作により90mgの淡黄
の粘稠な油状物質である混合物〔III〕を得た。
Glycerin 0.56 g, ethyl paradimethylaminocinnamate
1.46 g, ethyl 2-ethylhexanoate 1.14 g, potassium carbonate
Using 0.1 g, the same procedure as in Example 1 was carried out to obtain 90 mg of a pale yellow viscous oily mixture [III].

ただし、精製時のクロマト用溶出液としては、ジクロ
ロメタンを用いた。
However, dichloromethane was used as an eluate for chromatography during purification.

尚、上記混合物〔III〕のNMRを測定したところ、次の
とおりであった。
The NMR of the above mixture [III] was as follows.

測定条件は実施例1と同様である。 The measurement conditions are the same as in Example 1.

0.7−1.1(m,6H),1.1−1.6(m,9H),2.2−2.5(2
H),3.03(s,12H),4.42(d,4H,J=5Hz),5.3−5.6(1
H),6.23(d,2H,J=16Hz),6.65(d,4H,J=9Hz),7.42
(d,4H,J=9Hz),7.66(d,2H,J=16Hz) (1)UV−Aに対する防御効果 (イ)分光特性値 上記各化合物又は混合物について、紫外線吸収スペク
トルを測定したところ、その分光特性値は次表1のとお
りであった。
0.7-1.1 (m, 6H), 1.1-1.6 (m, 9H), 2.2-2.5 (2
H), 3.03 (s, 12H), 4.42 (d, 4H, J = 5Hz), 5.3-5.6 (1
H), 6.23 (d, 2H, J = 16 Hz), 6.65 (d, 4H, J = 9 Hz), 7.42
(D, 4H, J = 9 Hz), 7.66 (d, 2H, J = 16 Hz) (1) Protective effect against UV-A (a) Spectral characteristic value The ultraviolet absorption spectrum of each compound or mixture was measured. The spectral characteristic values are as shown in Table 1 below.

尚、各試料の測定時の溶媒としてはエタノールを用い
た。又、上記表1中、λmaxは最大吸収波長(吸収極大
値)を示し、εは最大吸収波長における分子吸光係数を
示し、Eは10mg/l溶液の360nmにおける吸光度をそれぞ
れ示す。
In addition, ethanol was used as a solvent at the time of measurement of each sample. In Table 1, λ max indicates the maximum absorption wavelength (maximum absorption value), ε indicates the molecular extinction coefficient at the maximum absorption wavelength, and E indicates the absorbance at 360 nm of a 10 mg / l solution.

さらに、上記表1中、比較例〔I〕,〔II〕はそれぞ
れ次の化合物である。
Further, in Table 1 above, Comparative Examples [I] and [II] are the following compounds, respectively.

比較例〔I〕:2−ハイドロキシ−4−メトキシベンゾフ
ェノン 比較例〔II〕:2,2′,4,4′−テトラハイドロキシベンゾ
フェノン 上記表1の分光特性値から、上記各化合物及び混合物
について次のような優秀性が認められた。
Comparative Example [I]: 2-Hydroxy-4-methoxybenzophenone Comparative Example [II]: 2,2 ′, 4,4′-tetrahydroxybenzophenone From the spectral characteristic values in Table 1 above, the following for each of the above compounds and mixtures was obtained. Such excellence was recognized.

(a)最大吸収波長が366nm付近にある。これはUV−A
領域において略中心に近い良好な位置である。
(A) The maximum absorption wavelength is around 366 nm. This is UV-A
This is a good position near the center in the area.

(b)分子吸光係数が63000〜67000と比較例〔I〕,
〔II〕のベンゾフェノン系吸収剤に比べてかなり高い。
(B) Comparative Example [I] with a molecular extinction coefficient of 63000-67000
It is considerably higher than the benzophenone-based absorbent of [II].

(c)単位重量当たりのUV−A吸収能を示す360nmにお
ける吸光度の値も上記ベンゾフェノン系吸収剤に比べて
高い。
(C) The value of the absorbance at 360 nm indicating the UV-A absorption capacity per unit weight is higher than that of the benzophenone-based absorbent.

尚、上記混合物〔III〕に関しては、その混合物〔II
I〕中から、本発明の化合物の一例である化合物〔C〕
のみを単離するのが困難であったため、化合物〔C〕に
ついての測定を行うことができず、混合物〔III〕の状
態のままで測定を行った。
As for the above mixture [III], the mixture [II
Compound [C] which is an example of the compound of the present invention from among [I]
Since it was difficult to isolate only the compound [C], the measurement could not be performed on the compound [C], and the measurement was performed in the state of the mixture [III].

しかしながら、この混合物〔III〕中において上記化
合物〔C〕は少なくとも60重量%以上含有されていると
認められる点、並びに混合物〔III〕中の化合物〔C〕
及び〔D〕がともにジメチルアミノシンナモイル基を有
するとともにそのジメチルアミノシンナモイル基自体が
UV−Aの略中心付近に最大吸収波長を持つ性質を具備す
る点を考慮すると、仮に化合物〔C〕のみについて紫外
線吸収スペクトルを測定しても同様に366nmの近辺に最
大吸収波長を有すると推定できる。
However, the compound [C] in the mixture [III] is considered to contain at least 60% by weight or more, and the compound [C] in the mixture [III]
And [D] both have a dimethylaminocinnamoyl group, and the dimethylaminocinnamoyl group itself is
Considering that the compound has the property of having a maximum absorption wavelength near the center of UV-A, even if only the compound [C] is measured for an ultraviolet absorption spectrum, it is estimated that the compound also has a maximum absorption wavelength near 366 nm. it can.

(ロ)動物を使用した防御効果試験 上記実施例における化合物〔I〕と混合物〔III〕
を、2又は5重量%配合したヒマシ油溶液についてUV−
A照射から皮膚を防御する効果を次に示した試験方法で
測定した。
(B) Protective effect test using animals Compound [I] and mixture [III] in the above Examples
Of a castor oil solution containing 2 or 5% by weight of UV-
The effect of protecting the skin from A-irradiation was measured by the following test method.

体重400〜500gの健常なハートレイ系白色モルモット
(各群5匹)の背部を毛刈りし、皮膚を露出させ、UV−
A照射30分前に予め8−メトキシソラレンの0.3%メタ
ノール溶液を4μl/cm2の量で塗布し、UV−Aに対する
感受性を高めた。
A healthy Hartley white guinea pig weighing 400 to 500 g (5 animals per group) shaves the back, exposes the skin, and
Thirty minutes before A irradiation, a 0.3% methanol solution of 8-methoxypsoralen was previously applied in an amount of 4 μl / cm 2 to increase the sensitivity to UV-A.

試料はUV−A照射15分前に2mg/cm2の量で均一に塗布
し、東芝FL20S−BLBランプ10灯にガラスフィルターを装
着してUV−Bを遮断したUV−A光源で15cmの距離から3.
5mW/cm2の強度で照射した。
The sample was applied evenly at 2 mg / cm2 15 minutes before UV-A irradiation, and a glass filter was attached to 10 Toshiba FL20S-BLB lamps, and a UV-A light source that blocked UV-B by a distance of 15 cm was used. From 3.
Irradiation was performed at an intensity of 5 mW / cm 2 .

照射後24時間経過した時点で皮膚の紅斑出現状態を観
察し、皮膚に紅斑を生じさせる最小のUV−A照射時間を
求めた。この時間と未塗布部皮膚における紅斑を生じさ
せる最小のUV−A照射時間を比較し、下式からUV−A防
止効果(protection factor A,PFA)を求めて各試料の
皮膚防御効果を測定した。
At 24 hours after the irradiation, the appearance of erythema on the skin was observed, and the minimum UV-A irradiation time for producing erythema on the skin was determined. The time and uncoated portion compares the minimum UV-A irradiation time cause erythema in the skin, UV-A-preventing effect (protection factor A, PF A) the following formula measuring the skin protective effect of each sample seeking did.

尚、式中t1は、試料を用いた皮膚に紅斑を生じさせる
最小UV−A照射時間であり、又、t2は、未塗布部皮膚に
紅斑を生じさせる最小UV−A照射時間である。
Incidentally, wherein t 1 is the minimum UV-A irradiation time causing erythema on the skin using a sample, and, t 2 is the minimum UV-A irradiation time causes erythema uncoated portion Skin .

以上のような測定の結果を、別紙図面の棒グラフに示
す。
The results of the above measurements are shown in the bar graph in the attached drawing.

そして、このような測定結果より、次のようなことが
明らかとなった。
And the following things became clear from such a measurement result.

(a)ヒマシ油ベースのみ塗布した比較例〔II〕ではUV
−Aを防御することはできない。
(A) In Comparative Example [II] where only castor oil base was applied, UV
-A cannot be defended.

(b)ベンゾフェノン系吸収剤5%配合品についての比
較例〔I〕との比較において、上記化合物〔I〕及び混
合物〔III〕は同一配合量でPFA6.5〜7.0と約2倍の高い
効果を示した。
(B) in comparison with the comparative examples of the benzophenone-based absorbers 5% mixed product [I], the compound [I] and mixtures [III] and PF A 6.5-7.0 same amount of about 2 times higher effect showed that.

(c)又、上記化合物〔I〕,混合物〔III〕の配合量
を2%に下げた場合でもPFA4.3〜4.6とより高い値を示
した。
(C) Further, the compound [I], the amount of the mixture (III) showed a higher value as the PF A from 4.3 to 4.6 even when reduced to 2%.

(2)相溶性 代表的な植物油であるヒマシ油並びに化粧品原料とし
ての汎用エステルである2−エチルヘキサン酸セチルに
対する室温における溶解度を測定したところ、次表2に
示されるように市販のベンゾフェノン系吸収剤に比べて
優秀な結果を得た。
(2) Compatibility Solubility at room temperature in castor oil, a typical vegetable oil, and cetyl 2-ethylhexanoate, a general-purpose ester as a cosmetic raw material, was measured, and as shown in Table 2, a commercially available benzophenone-based absorption was measured. Excellent results were obtained compared to the preparation.

尚、次表2において、比較例〔I〕,〔II〕はそれぞ
れ次の化合物である。
In Table 2, Comparative Examples [I] and [II] are the following compounds, respectively.

比較例〔I〕:2−ハイドロキシ−4メトキシベンゾフェ
ノン 比較例〔II〕:2,2′,4,4′−テトラハイドロキシベンゾ
フェノン (3)安全性 (イ)〜(ハ)に示すように、上記化合物〔I〕,
〔II〕,及び混合物〔III〕については、皮膚累積刺激
性,光毒性,接触感作性共に全く異常が認められず、皮
膚に対する安全性が確認された。
Comparative Example [I]: 2-hydroxy-4-methoxybenzophenone Comparative Example [II]: 2,2 ′, 4,4′-tetrahydroxybenzophenone (3) Safety As shown in (a) to (c), the above compounds [I],
With respect to [II] and the mixture [III], no abnormalities were observed in any of the cumulative skin irritation, phototoxicity and contact sensitization, and the safety on the skin was confirmed.

(イ)皮膚累積刺激性 体重2.8〜3.2kgの健常な日本白色ウサギを5匹用いて
背部を毛刈りし、シェービングした後、化合物〔I〕,
〔II〕及び混合物〔III〕の2又は5重量%ヒマシ油溶
液0.2gを2.5cm×2.5cmの範囲に1日1回ずつ5日間にわ
たって塗布し、刺激の有無を毎日肉眼で判定したが全く
異常は認められなかった。
(B) Cumulative skin irritation Using five healthy Japanese white rabbits weighing 2.8 to 3.2 kg, the back was shaved and shaved, and then the compound [I],
0.2 g of a castor oil solution of 2 or 5% by weight of [II] and the mixture [III] was applied once a day for 5 days in a range of 2.5 cm × 2.5 cm, and the presence or absence of irritation was visually determined every day. No abnormalities were observed.

尚、皮膚累積刺激性の試験結果を次表3に示す。 Table 3 shows the test results of the cumulative skin irritation.

(ロ)光毒性 化合物〔I〕,化合物〔II〕,混合物〔III〕の光毒
性について試料として2又は5重量%のヒマシ油溶液を
用いて行った。試験方法は、高瀬吉雄編「新しい皮膚の
生理と安全性,接触化学物質の毒性評価」〔清至書院出
版〕の277ページ記載の光毒性試験法に準じて行った。
(B) Phototoxicity The phototoxicity of the compound [I], the compound [II], and the mixture [III] was determined using a castor oil solution of 2 or 5% by weight as a sample. The test method was carried out according to the phototoxicity test method described on page 277 of "New skin physiology and safety, toxicity evaluation of contact chemicals" edited by Yoshio Takase.

ただし、本試験は、体重400〜500gの健常なハートレ
イ系白色モルモット5匹を使用し、総エネルギー量2.0
×108erg/cm2にて光照射を行った。
However, in this test, five healthy Hartley white guinea pigs weighing 400 to 500 g were used, and the total energy amount was 2.0.
Light irradiation was performed at × 10 8 erg / cm 2 .

そして、光毒性についての試験結果は、下記表4に示
すように、化合物〔I〕,化合物〔II〕,混合物〔II
I〕ともに光毒性反応が全く認められなかった。
As shown in Table 4 below, the results of the phototoxicity test were as follows: Compound [I], Compound [II], Mixture [II
I] In both cases, no phototoxic reaction was observed.

(ハ)接触感作原性 接触感作原性についての試験を、高瀬吉雄編「新しい
皮膚の生理と安全性,接触化学物質の毒性評価」〔清至
書院出版〕の262ページ記載のModified法(Adijuvant a
nd Patch Test法)に準じて行った。
(C) Contact sensitizing properties The test for contact sensitizing properties was conducted using the Modified method described on page 262 of Takase Yoshio, edited by Yoshio Takase, “New Skin Physiology and Safety, Toxicity Evaluation of Contact Chemicals” (Seishinshoin Publishing). (Adijuvant a
nd Patch Test method).

ただし、本試験は、体重400〜500gの健常なハートレ
イ系白色モルモット10匹を使用し、感作惹起には、化合
物〔I〕及び混合物〔III〕については5重量%ヒマシ
油溶液を、化合物〔II〕については2重量%ヒマシ油溶
液をそれぞれ使用し、又、誘発試験には、化合物
〔I〕,混合物〔III〕については5,1,0.1重量%のヒマ
シ油溶液を、化合物〔II〕については2,1,0.1重量%の
ヒマシ油溶液をそれぞれ用いた。
However, in this test, 10 healthy Hartley white guinea pigs weighing 400 to 500 g were used. To induce sensitization, a 5% by weight castor oil solution was used for the compound [I] and the mixture [III]. For II), a 2% by weight castor oil solution was used, and for the provocation test, for the compound [I] and the mixture [III], a 5,1,0.1% by weight castor oil solution was used. For each, a castor oil solution of 2,1,0.1% by weight was used.

そして、上記接触感作原性についての試験結果おいて
は、次表5に示すように、化合物〔I〕,〔II〕及び混
合物〔III〕ともに感作性が全く認められなかった。
As shown in the following Table 5, no sensitization was observed for the compounds [I] and [II] and the mixture [III] in the test results of the contact sensitization.

次に、上記化合物〔I〕及び混合物〔III〕を化粧料
に配合する場合の処方例について示す。
Next, formulation examples when the compound [I] and the mixture [III] are blended in a cosmetic will be described.

処方例1 (重量%) 液相 ステアリン酸 10.0 ステアリルアルコール 4.0 ステアリン酸ブチル 6.0 モノステアリン酸グリセリン 2.0 パラメトキシケイヒ酸−2−エチルヘキシル2.0 化合物〔I〕 2.0 水相 プロピレングリコール 10.0 グリセリン 4.0 水酸化カリウム 0.4 香料及び防腐剤 微量 精製水 残量 合計 100.0 処方例2 (重量%) 液相 ステアリン酸 5.0 ミツロウ 1.0 ラノリン 0.5 モノステアリン酸グリセリン 0.5 2−エチルヘキサン酸セチル 7.0 ミリスチン酸オクチルドデシル 3.0 セスキオレイン酸ソルビタン 1.0 パラジメチルアミノ安息香酸−2−エチルヘキシ
ル 4.0 混合物〔III〕 3.0 水相 プロピレングリコール 2.0 トリエタノールアミン 0.6 カルボキシビニルポリマー 0.2 香料及び防腐剤 微量 精製水 残量 合計 100.0 尚、上記両処方例においては、UV−A領域の紫外線吸
収剤である化合物〔I〕若しくは混合物〔III〕のみな
らず、UV−B領域の紫外線吸収剤であるパラメトキシケ
イヒ酸−2−エチルヘキシル若しくはパラジメチルアミ
ノ安息香酸−2−エチルヘキシルをもそれぞれ含有した
ため、双方の領域の紫外線を好適に吸収できる化粧料を
提供できるという利点がある。
Formulation Example 1 (% by weight) Liquid phase Stearic acid 10.0 Stearyl alcohol 4.0 Butyl stearate 6.0 Glycerin monostearate 2.0 2-Ethylhexyl paramethoxycinnamate 2.0 Compound [I] 2.0 Water phase Propylene glycol 10.0 Glycerin 4.0 Potassium hydroxide 0.4 Fragrance And preservatives Micro- purified water Total remaining amount 100.0 Formulation Example 2 (% by weight) Liquid phase stearic acid 5.0 beeswax 1.0 lanolin 0.5 glyceryl monostearate 0.5 cetyl 2-ethylhexanoate 7.0 octyldodecyl myristate 3.0 sorbitan sesquioleate 1.0 paradimethyl aminobenzoic acid-2-ethylhexyl 4.0 mixture (III) 3.0 aqueous phase propylene glycol 2.0 triethanolamine 0.6 carboxyvinyl polymer 0.2 perfume and preservative trace purified water Balance total 100.0 in the above both formulation example, UV-A Not only the compound [I] or the mixture [III] which is a UV absorber in the UV region, but also 2-ethylhexyl paramethoxycinnamate or 2-ethylhexyl paradimethylaminobenzoate which is a UV absorber in the UV-B region. Since each of them is contained, there is an advantage that it is possible to provide a cosmetic that can appropriately absorb ultraviolet rays in both regions.

(発明の効果) (イ)叙上のように、本発明によって、1,2−ビス(ジ
メチルアミノシンナモイルオキシ)プロパン誘導体なる
全く新規な化合物を提供しうるに至った。
(Effects of the Invention) (a) As described above, the present invention can provide a completely novel compound of a 1,2-bis (dimethylaminocinnamoyloxy) propane derivative.

特に、本発明の化合物は、UV−A(320〜400nm)の領
域において、その略中心部である366nmの付近に吸収極
大を有し、しかもその吸収極大値における分子吸光係数
が高いため、UV−A専用の紫外線吸収剤としての提供を
確実に行わしめるという実益がある。
In particular, the compound of the present invention has an absorption maximum near 366 nm, which is a substantially central portion thereof, in a UV-A (320 to 400 nm) region, and furthermore, has a high molecular extinction coefficient at the absorption maximum, so -A has the real benefit that it can be reliably provided as an ultraviolet absorber exclusively for A.

(ロ)さらに、本発明の紫外線吸収剤は、上述のように
吸収極大値等の分光特性値が良好な上記化合物を含有し
たものなるため、UV−A領域の紫外線の吸収効果に優
れ、又、相溶性が良好であり、しかも、皮膚に対する刺
激や光毒性,感作性等が全くなく、安全性が非常に良好
であった。
(B) Further, since the ultraviolet absorbent of the present invention contains the above compound having a good spectral characteristic value such as an absorption maximum value as described above, it has an excellent effect of absorbing ultraviolet rays in the UV-A region, and Good compatibility, no irritation to skin, no phototoxicity, no sensitization, etc., and very good safety.

よって、従来に比べて安全性,相溶性,吸収効果等の
すべての点において優れたUV−A領域専用の紫外線吸収
剤を提供することが可能となり、UV−A用の紫外線吸収
剤の汎用性を高めることができるという顕著な効果を有
するに至った。
Therefore, it is possible to provide a UV absorber exclusively for the UV-A region, which is superior in all aspects, such as safety, compatibility, absorption effect, etc., as compared with the conventional one, and the versatility of the UV absorber for UV-A Can be enhanced.

【図面の簡単な説明】[Brief description of the drawings]

図面は、UV−A領域の紫外線に対する防御効果試験とし
てのPFAの値を示すグラフである。
Drawings is a graph showing the value of PF A as protective effect test against ultraviolet rays UV-A region.

Claims (2)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】一般式 (R1は炭素数1〜18のアルキル基又は炭素数2〜18のア
シル基、R2はオルト又はパラ位のジメチルアミノ基〔−
N(CH3)2〕を示す)で示される1,2−ビス(ジメチルアミ
ノシンナモイルオキシ)プロパン誘導体。
(1) General formula (R 1 is an alkyl group having 1 to 18 carbon atoms or an acyl group having 2 to 18 carbon atoms, and R 2 is an ortho- or para-position dimethylamino group [−
N (CH 3 ) 2 ]), which is a 1,2-bis (dimethylaminocinnamoyloxy) propane derivative represented by the formula:
【請求項2】一般式 (R1は炭素数1〜18のアルキル基又は炭素数2〜18のア
シル基、R2はオルト又はパラ位のジメチルアミノ基〔−
N(CH3)2〕を示す)で示される1,2−ビス(ジメチルアミ
ノシンナモイルオキシ)プロパン誘導体を含有してなる
ことを特徴とする紫外線吸収剤。
2. The general formula (R 1 is an alkyl group having 1 to 18 carbon atoms or an acyl group having 2 to 18 carbon atoms, and R 2 is an ortho- or para-position dimethylamino group [−
N (CH 3 ) 2 ]), which comprises a 1,2-bis (dimethylaminocinnamoyloxy) propane derivative represented by the following formula:
JP15047188A 1988-06-17 1988-06-17 1,2-bis (dimethylaminocinnamoyloxy) propane derivative and ultraviolet absorber containing the propane derivative Expired - Lifetime JP2759325B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP15047188A JP2759325B2 (en) 1988-06-17 1988-06-17 1,2-bis (dimethylaminocinnamoyloxy) propane derivative and ultraviolet absorber containing the propane derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15047188A JP2759325B2 (en) 1988-06-17 1988-06-17 1,2-bis (dimethylaminocinnamoyloxy) propane derivative and ultraviolet absorber containing the propane derivative

Publications (2)

Publication Number Publication Date
JPH023638A JPH023638A (en) 1990-01-09
JP2759325B2 true JP2759325B2 (en) 1998-05-28

Family

ID=15497632

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15047188A Expired - Lifetime JP2759325B2 (en) 1988-06-17 1988-06-17 1,2-bis (dimethylaminocinnamoyloxy) propane derivative and ultraviolet absorber containing the propane derivative

Country Status (1)

Country Link
JP (1) JP2759325B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0539601B1 (en) * 1991-05-09 1997-04-09 Shiseido Company Limited Cinnamic acid/glycerol adduct, ultraviolet absorber, and dermatologic preparation
JP2923358B2 (en) * 1991-05-09 1999-07-26 株式会社資生堂 Glycerin cinnamate adduct, UV absorber and external preparation for skin

Also Published As

Publication number Publication date
JPH023638A (en) 1990-01-09

Similar Documents

Publication Publication Date Title
US5518713A (en) Benzoxazole derivatives, the use thereof as sunscreens and cosmetic compositions containing them
US4584190A (en) Novel chalcone derivatives and ultraviolet absorbers comprising the same
US5501850A (en) Use of benzimidazole derivatives as light protection filters
NL7907446A (en) AGAINST LIGHT PROTECTIVE AGENT.
NL8302110A (en) Novel 3-benzylidene camps, process for their preparation and use of these compounds for protection against UV radiation.
EP0570838A1 (en) S-triazine derivatives as light stabilisers
JPH11507941A (en) Chemical compound and method for producing the same
KR20100135793A (en) Dimeric benzylidene malonates
JPH07503963A (en) Triazine derivative with UV filter properties
US6280711B1 (en) Photoresponsive sunscreen compositions
JP2759325B2 (en) 1,2-bis (dimethylaminocinnamoyloxy) propane derivative and ultraviolet absorber containing the propane derivative
US5144081A (en) Dialkoxybenzylidene-camphor derivatives
KR20060052830A (en) Dibenzoilmethane derivative compounds, the use thereof in the form of photoactivable solar filters and cosmetic compositions containing said compounds
AU705235B2 (en) Photostable cosmetic light screening compositions
ES2338025T3 (en) DIMERIC DERIVATIVES OF 5,6-DIFENIL-1,2,4-TRIAZINE AND ITS USE AS SUN PROTECTING AGENTS
JPS6311343B2 (en)
ES2341558T3 (en) MONOMERIC DERIVATIVES OF 5,6-DIFENIL-1,2,4-TRIAZINE AND ITS USES.
JP5731452B2 (en) Novel benzotriazole derivative compound and water-soluble ultraviolet absorber containing the same
CA2005236A1 (en) Ultraviolet radiation absorbing compositions of bis-1,3-diketone derivatives of cyclohexane
AU587211B2 (en) Ultra violet agents
JPH02243647A (en) 4-hydroxydibenzoylmethane derivative, uv light absorbent and cosmetic
EP0722714A2 (en) Benzoxazole derivatives, the use thereof as sunscreens and cosmetic compositions containing them
JPH01211546A (en) Unsaturated 3-benzylidenecamfer derivative, its production and cosmetics composition
JP2002053527A (en) 5,5-diaryl-2,4-pentadienoic acid ester-based compound and ultraviolet absorber comprising the same compound as active ingredient
KR0149053B1 (en) Cinnamic acid derivatives and preparation of those compounds